ZFX regulates the expression of SET nuclear proto-oncogene (SET), also known as protein phosphatase 2A inhibitor (I2PP2A) [34], a gene associated with tau protein hyperphosphorylation in Alzheimer’s disease [35]. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.